Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design

Authors:

Abstract
No abstract available
Funding Information
  • Taiwan Ministry of Science and Technology
  • National Health Research Institutes (BP-105-PP-01, BP-106-PP-01)
  • Taiwan Ministry of Health and Welfare (MOHW103-TDU-212-114006)

This publication has 39 references indexed in Scilit: